India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:544179 has a market cap or net worth of INR 328.64 billion. The enterprise value is 329.75 billion.
| Market Cap | 328.64B |
| Enterprise Value | 329.75B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 923.03M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.87% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 245.48M |
Valuation Ratios
The trailing PE ratio is 71.15 and the forward PE ratio is 51.48.
| PE Ratio | 71.15 |
| Forward PE | 51.48 |
| PS Ratio | 3.46 |
| PB Ratio | 7.13 |
| P/TBV Ratio | 7.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 71.39 |
| EV / Sales | 3.47 |
| EV / EBITDA | 57.45 |
| EV / EBIT | 59.44 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | n/a |
| Interest Coverage | 8.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.92% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 20.96M |
| Profits Per Employee | 1.02M |
| Employee Count | 4,534 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544179 has paid 223.30 million in taxes.
| Income Tax | 223.30M |
| Effective Tax Rate | 4.61% |
Stock Price Statistics
The stock price has increased by +8.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +8.84% |
| 50-Day Moving Average | 349.14 |
| 200-Day Moving Average | 320.86 |
| Relative Strength Index (RSI) | 51.76 |
| Average Volume (20 Days) | 83,417 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544179 had revenue of INR 95.03 billion and earned 4.62 billion in profits. Earnings per share was 4.99.
| Revenue | 95.03B |
| Gross Profit | 13.32B |
| Operating Income | 5.55B |
| Pretax Income | 4.84B |
| Net Income | 4.62B |
| EBITDA | 5.74B |
| EBIT | 5.55B |
| Earnings Per Share (EPS) | 4.99 |
Balance Sheet
The company has 3.04 billion in cash and 3.50 billion in debt, giving a net cash position of -1.11 billion.
| Cash & Cash Equivalents | 3.04B |
| Total Debt | 3.50B |
| Net Cash | -1.11B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 46.12B |
| Book Value Per Share | 49.97 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 14.01%, with operating and profit margins of 5.84% and 4.86%.
| Gross Margin | 14.01% |
| Operating Margin | 5.84% |
| Pretax Margin | 5.10% |
| Profit Margin | 4.86% |
| EBITDA Margin | 6.04% |
| EBIT Margin | 5.84% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544179 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.87% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |